Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Galera Therapeutics, Inc. per 2025 Jun 30 adalah -8.46 MM.
- Nilai net income untuk Galera Therapeutics, Inc. per 2025 Jun 30 adalah -13.18 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -8.46 | -13.18 | |
2025-03-31 | -11.54 | -16.17 | |
2024-12-31 | -14.15 | -18.96 | |
2024-09-30 | -17.71 | -19.61 | |
2024-06-30 | -25.05 | -29.11 | |
2024-03-31 | -37.65 | -45.75 | |
2023-12-31 | -46.95 | -59.08 | |
2023-09-30 | -54.96 | -69.68 | |
2023-06-30 | -56.83 | -70.64 | |
2023-03-31 | -51.95 | -64.49 | |
2022-12-31 | -51.23 | -62.22 | |
2022-09-30 | -52.54 | -62.84 | |
2022-06-30 | -59.88 | -69.43 | |
2022-03-31 | -69.04 | -77.26 | |
2021-12-31 | -73.37 | -80.53 | |
2021-09-30 | -77.81 | -83.79 | |
2021-06-30 | -73.59 | -78.25 | |
2021-03-31 | -70.22 | -74.52 | |
2020-12-31 | -70.55 | -74.22 | |
2020-09-30 | -67.78 | -70.82 | |
2020-06-30 | |||
2020-03-31 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | -0.36 | -0.36 |
2024-06-30 | -0.56 | -0.56 |
2024-03-31 | -0.93 | -0.93 |
2023-12-31 | -1.33 | |
2023-09-30 | -1.84 | -1.84 |
2023-06-30 | -2.13 | -2.13 |
2023-03-31 | -2.21 | -2.21 |
2022-12-31 | -2.30 | |
2022-09-30 | -2.35 | -2.35 |
2022-06-30 | -2.61 | -2.61 |
2022-03-31 | -2.95 | -2.95 |
2021-12-31 | -3.12 | |
2021-09-30 | -3.30 | -3.30 |
2021-06-30 | -3.12 | -3.12 |
2021-03-31 | -2.99 | -2.99 |
2020-12-31 | -2.98 | |
2020-09-30 | -3.26 | -3.26 |
2020-06-30 | -4.42 | -4.42 |
2020-03-31 | -6.68 | -6.68 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Galera Therapeutics, Inc. per 2025 Jun 30 adalah -8.33 MM.
- Nilai cash from investing activities untuk Galera Therapeutics, Inc. per 2025 Jun 30 adalah -0.05 MM.
- Nilai kas dari aktivitas pendanaan untuk Galera Therapeutics, Inc. per 2025 Jun 30 adalah 2.86 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -8.33 | -0.05 | 2.86 |
2025-03-31 | -9.59 | -0.05 | 2.86 |
2024-12-31 | -12.14 | -0.05 | 2.22 |
2024-09-30 | -19.72 | 3.98 | -0.23 |
2024-06-30 | -29.94 | 14.44 | 1.90 |
2024-03-31 | -37.97 | 21.99 | 3.71 |
2023-12-31 | -44.85 | 27.29 | 31.50 |
2023-09-30 | -48.88 | 26.10 | 34.43 |
2023-06-30 | -45.57 | 20.24 | 32.31 |
2023-03-31 | -43.71 | 19.30 | 30.50 |
2022-12-31 | -43.43 | 23.99 | 3.89 |
2022-09-30 | -46.93 | 40.87 | 1.21 |
2022-06-30 | -56.12 | -6.78 | 41.81 |
2022-03-31 | -64.04 | 2.35 | 67.65 |
2021-12-31 | -67.96 | 5.24 | 66.71 |
2021-09-30 | -66.96 | 2.44 | 66.92 |
2021-06-30 | -63.84 | 59.90 | 26.53 |
2021-03-31 | -62.45 | 53.83 | 0.73 |
2020-12-31 | -59.54 | 36.55 | 20.51 |
2020-09-30 | -58.36 | -22.10 | 79.98 |
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/libro untuk Galera Therapeutics, Inc. pada 2025 Jun 30 adalah -0.05.
- p/tbv untuk Galera Therapeutics, Inc. pada 2025 Jun 30 adalah -0.05.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | -0.05 | -0.05 | |
2025-03-31 | -0.38 | -0.05 | -0.05 |
2024-12-31 | -0.04 | -0.04 | |
2024-09-30 | -0.19 | -0.04 | -0.04 |
2024-06-30 | -0.12 | -0.04 | -0.04 |
2024-03-31 | -0.07 | -0.06 | |
2023-12-31 | -0.11 | -0.06 | -0.06 |
2023-09-30 | -0.11 | -0.07 | -0.07 |
2023-06-30 | -1.98 | -1.31 | -1.27 |
2023-03-31 | -1.73 | -0.99 | |
2022-12-31 | -0.44 | -0.42 | |
2022-09-30 | -0.56 | -0.54 | |
2022-06-30 | -0.45 | -0.49 | -0.47 |
2022-03-31 | -0.79 | -1.09 | -1.03 |
2021-12-31 | -1.46 | -2.83 | -2.64 |
2021-09-30 | -2.74 | -8.41 | -7.49 |
2021-06-30 | |||
2021-03-31 | -0.66 | -4.62 | -3.56 |
2020-12-31 | -0.65 | 7.92 | 16.27 |
2020-09-30 | -0.68 | 1.96 | 2.24 |
2020-06-30 | -0.72 | 1.20 | 1.30 |
2020-03-31 | -0.80 | 0.91 | 0.96 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Galera Therapeutics, Inc. pada 2025 Jun 30 adalah -0.11.
- EBIT (3 tahun) / EV untuk Galera Therapeutics, Inc. pada 2025 Jun 30 adalah -0.25.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.11 | -0.25 |
2025-03-31 | -0.13 | -0.29 |
2024-12-31 | -0.13 | -0.32 |
2024-09-30 | -0.20 | -0.37 |
2024-06-30 | -0.32 | -0.44 |
2024-03-31 | -0.52 | -0.53 |
2023-12-31 | -0.52 | -0.54 |
2023-09-30 | -0.54 | -0.55 |
2023-06-30 | -0.63 | -0.69 |
2023-03-31 | -0.60 | -0.69 |
2022-12-31 | -2.11 | -2.44 |
2022-09-30 | -2.37 | -2.55 |
2022-06-30 | -5.17 | -4.96 |
2022-03-31 | -1.86 | -1.65 |
2021-12-31 | -0.80 | -0.67 |
2021-09-30 | -0.44 | -0.37 |
2021-06-30 | ||
2021-03-31 | -2.12 | -1.55 |
2020-12-31 | -2.28 | -1.54 |
2020-09-30 | -2.14 | -1.16 |
2020-06-30 | -2.08 | -1.31 |
2020-03-31 | -0.30 | -0.19 |
Efektivitas Manajemen
- roa untuk Galera Therapeutics, Inc. pada 2025 Jun 30 adalah -0.99.
- roic untuk Galera Therapeutics, Inc. pada 2025 Jun 30 adalah -2.42.
- croic untuk Galera Therapeutics, Inc. pada 2025 Jun 30 adalah -1.01.
- ocroic untuk Galera Therapeutics, Inc. pada 2025 Jun 30 adalah -1.43.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.99 | -2.42 | -1.01 | -1.43 | |
2025-03-31 | -1.00 | -2.46 | -2.00 | -2.47 | |
2024-12-31 | -0.75 | -2.14 | -1.74 | -2.15 | |
2024-09-30 | -0.77 | -2.05 | -0.96 | -2.11 | |
2024-06-30 | -0.77 | -2.60 | -0.70 | -2.16 | |
2024-03-31 | -1.58 | -2.78 | 0.46 | -1.95 | |
2023-12-31 | -1.37 | -2.78 | 0.46 | -1.95 | |
2023-09-30 | -1.16 | -2.04 | 0.20 | -1.32 | |
2023-06-30 | -1.06 | ||||
2023-03-31 | -0.88 | ||||
2022-12-31 | -0.64 | ||||
2022-09-30 | -0.70 | ||||
2022-06-30 | -0.67 | ||||
2022-03-31 | -1.14 | ||||
2021-12-31 | -1.00 | -13.70 | |||
2021-09-30 | -0.85 | -3.17 | |||
2021-06-30 | -0.68 | -1.94 | |||
2021-03-31 | -0.57 | -1.40 | |||
2020-12-31 | -0.60 | -1.07 | -11.16 | -0.37 | -8.95 |
2020-09-30 | -0.89 | -2.58 | -2.80 | -0.02 | -2.31 |
2020-06-30 | -0.74 | -1.66 | -1.64 | -0.01 | -1.37 |
2020-03-31 | -0.68 | -0.98 | -1.11 | 0.24 | -0.93 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1563577 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |